CT
Cambridge Trust’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $102K | Hold |
1,500
| – | – | ﹤0.01% | 340 |
|
2023
Q4 | $93.9K | Hold |
1,500
| – | – | ﹤0.01% | 346 |
|
2023
Q3 | $68.1K | Hold |
1,500
| – | – | ﹤0.01% | 387 |
|
2023
Q2 | $84.2K | Hold |
1,500
| – | – | ﹤0.01% | 373 |
|
2023
Q1 | $67.8K | Hold |
1,500
| – | – | ﹤0.01% | 408 |
|
2022
Q4 | $61K | Hold |
1,500
| – | – | ﹤0.01% | 430 |
|
2022
Q3 | $98K | Hold |
1,500
| – | – | ﹤0.01% | 366 |
|
2022
Q2 | $91K | Hold |
1,500
| – | – | ﹤0.01% | 406 |
|
2022
Q1 | $94K | Hold |
1,500
| – | – | ﹤0.01% | 432 |
|
2021
Q4 | $114K | Buy |
+1,500
| New | +$114K | ﹤0.01% | 405 |
|